Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1992-12-22
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0002-953X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
149
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1758; author reply 1759-60
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1443265-Antiparkinson Agents,
pubmed-meshheading:1443265-Combined Modality Therapy,
pubmed-meshheading:1443265-Delirium,
pubmed-meshheading:1443265-Electroconvulsive Therapy,
pubmed-meshheading:1443265-Humans,
pubmed-meshheading:1443265-Mental Disorders,
pubmed-meshheading:1443265-Parkinson Disease
|
pubmed:year |
1992
|
pubmed:articleTitle |
ECT and delirium in Parkinson's disease.
|
pubmed:publicationType |
Letter,
Comment
|